In distribution since 1926, we know what works. Today, we are strengthening our presence in the U.S. nutraceutical market.

Faravelli Inc. announces its partnership with PROSOL, becoming the official U.S. distributor of RiboMIX SC, a line of nucleotide-based ingredients.

This partnership combines Faravelli’s local expertise with PROSOL’s scientific leadership in yeast-derived functional ingredients.
With decades of experience, PROSOL is a recognized leader in nucleotide development and ingredient standardization, delivering high-quality solutions for advanced nutraceutical formulations.

A key milestone further reinforces this positioning: the recent completion of a randomized, double-blind, placebo-controlled clinical study in Mild Cognitive Impairment (MCI), strengthening the role of nucleotide-based ingredients as clinically supported solutions for cognitive health.

Through this agreement, Faravelli Inc. provides U.S. customers with direct access to PROSOL’s portfolio, along with dedicated technical and commercial support. 

Together, Faravelli Inc. and PROSOL aim to support the development of next-generation nutraceutical solutions for cognitive performance and healthy ageing.

.